AViTA Corporation (4735) - Total Assets
Based on the latest financial reports, AViTA Corporation (4735) holds total assets worth NT$1.80 Billion TWD (≈ $56.84 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
AViTA Corporation - Total Assets Trend (2017–2025)
This chart illustrates how AViTA Corporation's total assets have evolved over time, based on quarterly financial data. Also see 4735 market cap for the company's overall valuation and market capitalisation.
AViTA Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
AViTA Corporation's total assets of NT$1.80 Billion consist of 49.9% current assets and 50.1% non-current assets. Review AViTA Corporation balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 19.7% |
| Accounts Receivable | NT$77.72 Million | 5.7% |
| Inventory | NT$88.25 Million | 6.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how AViTA Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See AViTA Corporation share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AViTA Corporation's current assets represent 49.9% of total assets in 2025, a decrease from 63.4% in 2017.
- Cash Position: Cash and equivalents constituted 19.7% of total assets in 2025, up from 16.8% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 6.5% of total assets.
AViTA Corporation Competitors by Total Assets
Key competitors of AViTA Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
LENSAR Inc
NASDAQ:LNSR
|
USA | $69.56 Million |
|
Lumos Diagnostics Holdings Ltd
AU:LDX
|
Australia | AU$21.12 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
AViTA Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.58 | 2.15 | 1.53 |
| Quick Ratio | 1.34 | 1.86 | 1.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$388.02 Million | NT$416.09 Million | NT$396.56 Million |
AViTA Corporation - Advanced Valuation Insights
This section examines the relationship between AViTA Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.22 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | NT$1.35 Billion |
| Market Capitalization | $43.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values AViTA Corporation's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: AViTA Corporation's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for AViTA Corporation (2017–2025)
The table below shows the annual total assets of AViTA Corporation from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$1.35 Billion ≈ $42.68 Million |
+13.74% |
| 2024-12-31 | NT$1.19 Billion ≈ $37.52 Million |
-3.88% |
| 2023-12-31 | NT$1.24 Billion ≈ $39.04 Million |
-7.38% |
| 2022-12-31 | NT$1.34 Billion ≈ $42.15 Million |
-21.06% |
| 2021-12-31 | NT$1.69 Billion ≈ $53.40 Million |
-33.09% |
| 2020-12-31 | NT$2.53 Billion ≈ $79.80 Million |
+143.27% |
| 2019-12-31 | NT$1.04 Billion ≈ $32.80 Million |
-3.50% |
| 2018-12-31 | NT$1.08 Billion ≈ $33.99 Million |
+9.85% |
| 2017-12-31 | NT$982.28 Million ≈ $30.95 Million |
-- |
About AViTA Corporation
AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation wa… Read more